Telampin S Tablet 40/2.5 mg
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
BC World Pharma Co., Ltd.
MFDS item code 202204036 · Approved 2022.11.08
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively manage blood pressure in patients with primary hypertension whose blood pressure is not adequately controlled with monotherapy of telmisartan or esamlodipine (amlodipine).
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or S-amlodipine (amlodipine)); however, direct conversion to this drug may be considered if blood pressure is not controlled with the individual components, as follows. - 40/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this drug 40/5 milligrams. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, for patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ○ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
○ Children: Administration of this drug is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.
This medication may pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, so it should not be used by pregnant women or women who may become pregnant. This medication should not be used by patients with allergies to the active ingredients or similar drugs, patients with severe liver impairment or obstructive biliary disease, severe aortic stenosis patients, patients in shock, or patients with diabetes or severe kidney impairment. Particular caution is needed when using this medication in patients with primary hyperaldosteronism, certain heart valve diseases, liver impairment, gastrointestinal diseases, renovascular hypertension, severe hypotension, patients requiring dialysis, and elderly patients. When taking this medication, there may be side effects such as headache, dizziness, edema, palpitations, nausea; thus, if symptoms are severe or persist, consultation with a doctor is advised. If symptoms of hypotension occur, immediately lie down and seek medical assistance if necessary. It is crucial to have regular tests as kidney function or blood potassium levels may fluctuate. This medication may interact with other antihypertensive agents or certain medications, so it is important to inform your doctor or pharmacist if you are taking other drugs. It is advisable not to use this medication during pregnancy or breastfeeding; if pregnancy is confirmed, immediately discontinue use. The safety and efficacy of this medication have not been sufficiently established in children, so it is not recommended for them. Older adults may respond more sensitively to this medication, requiring dosage adjustment and caution. In case of overdose, severe hypotension, dizziness, or heart problems may occur, so you should immediately visit a healthcare facility and receive appropriate treatment. Keep this medication out of the reach of children, and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.
Oblong tablet consisting of a light yellow and light blue two layers
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
BC World Pharma Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Healthcare Co., Ltd.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.